Editorial
doi: 10.1001/jama.2024.12814.
Are Blood Tests for Alzheimer Disease Ready for Prime Time?
Affiliations
- PMID: 39068544
- DOI: 10.1001/jama.2024.12814
Item in Clipboard
Editorial
Are Blood Tests for Alzheimer Disease Ready for Prime Time?
JAMA.
.
No abstract available
Comment in
-
Changes in Alzheimer Disease Blood Biomarkers and Associations With Incident All-Cause Dementia.JAMA. 2024 Oct 15;332(15):1258-1269. doi: 10.1001/jama.2024.6619. JAMA. 2024. PMID: 39068543
-
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care.JAMA. 2024 Oct 15;332(15):1245-1257. doi: 10.1001/jama.2024.13855. JAMA. 2024. PMID: 39068545
Similar articles
-
Phenotyping Alzheimer's disease with blood tests.Science. 2021 Aug 6;373(6555):626-628. doi: 10.1126/science.abi5208. Science. 2021. PMID: 34353941 No abstract available.
-
Emerging blood-based biomarkers for Alzheimer disease.Cleve Clin J Med. 2020 Aug 31;87(9):537-539. doi: 10.3949/ccjm.87a.20133. Cleve Clin J Med. 2020. PMID: 32868302 No abstract available.
-
Alzheimer's drug approval spotlights blood tests.Science. 2021 Jul 23;373(6553):373-374. doi: 10.1126/science.373.6553.373. Science. 2021. PMID: 34437096 No abstract available.
-
Identifying and validating biomarkers for Alzheimer's disease.Trends Biotechnol. 2011 Jan;29(1):26-32. doi: 10.1016/j.tibtech.2010.09.007. Epub 2010 Oct 23. Trends Biotechnol. 2011. PMID: 20971518 Free PMC article. Review.
-
Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances.J Neurol Neurosurg Psychiatry. 2021 Nov;92(11):1231-1241. doi: 10.1136/jnnp-2021-327370. Epub 2021 Sep 11. J Neurol Neurosurg Psychiatry. 2021. PMID: 34510001 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
